ung cancer specialists often collaborate across disciplines in tumor boards to improve patient care. We also value cross-discipline collaboration. That’s why we have the Lung Cancer Initiative at Johnson & Johnson, a multidisciplinary R&D team working across medical technology, pharmaceutical and behavioral-change groups striving to prevent, intercept and treat lung cancer.